title: [Evaluation of rest-activity rhythms in advanced non-small-cell lung cancer (NSCLC) patients. Importance of corticotherapy?].
abstract: The circadian structure (i.e. rest-activity cycle) was evaluated by actometry in a group of 25 advanced NSCLC patients. A better circadian profile was observed in the 6 patients treated with corticosteroïds. However those patients had also a shortened survival.
authors.affiliation: Service d'oncologie médicale, clinique Saint-Joseph, rue de Hesbaye 75, 4000, Liège, Belgique. christian.focan@lescliniquesstjoseph.be
authors.forename: C
authors.initials: C
authors.lastname: Focan
authors.forename: C
authors.initials: C
authors.lastname: Mormont
authors.forename: N
authors.initials: N
authors.lastname: Moeneclaye
authors.forename: D
authors.initials: D
authors.lastname: Focan-Henrard
authors.forename: J
authors.initials: J
authors.lastname: Waterhouse
mesh_terms: D000305:Adrenal Cortex Hormones / Q000494:pharmacology* / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000503:physiopathology*; D019454:Chronotherapy; D002940:Circadian Rhythm / Q000187:drug effects; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000503:physiopathology*; D009043:Motor Activity / Q000187:drug effects
chemical_list: D000305:Adrenal Cortex Hormones